IHL Financials Comparison to Peers, page-5

Also something worth noting EXL since last posting has dropped $100m in mcap, that is $100m that is now spread across the rest of the medcann pool. With the mcap of EXL sitting at $430m and the disparity between 2nd, 3rd and the rest of the field it would appear further pullback is in play for EXL to level out the playing field. This further pullback in EXL would free up available funds to further invest in other play in the medcann sector, will be interesting to see how much of that will reach IHL over the next few weeks.